Company Filing History:
Years Active: 2007-2016
Title: Fumitaka Mafune: Innovator in Nucleic Acid and Nano-Substance Technologies
Introduction
Fumitaka Mafune is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the fields of nucleic acid decomposition and nano-substance production. With a total of 4 patents to his name, Mafune's work is recognized for its innovative approaches and practical applications.
Latest Patents
Mafune's latest patents include a decomposition method and apparatus for nucleic acid polymers. This method involves bonding a probe nucleic acid polymer with a microparticle to create a probe nucleic acid polymer-bonded microparticle. The process continues by adding a target nucleic acid polymer to this bonded microparticle, energizing it into a high-energy state, and utilizing energy transfer to decompose the target nucleic acid polymer. Another notable patent is a method for producing an accumulated product of a nano-substance. This method allows for the low-cost production of nano-substance accumulations through a simple process that requires minimal energy and controlled conditions. The technique involves crystallizing a protein in a solvent where the protein and nano-substance coexist, leading to the accumulation of the nano-substance within the protein crystals.
Career Highlights
Throughout his career, Fumitaka Mafune has worked with notable organizations, including Genesis Research Institute and Toyota Motor Corporation. His experience in these companies has contributed to his expertise in research and development in innovative technologies.
Collaborations
Mafune has collaborated with esteemed colleagues such as Yoshihiro Takeda and Tamotsu Kondow. These partnerships have further enhanced his research capabilities and broadened the impact of his inventions.
Conclusion
Fumitaka Mafune is a distinguished inventor whose work in nucleic acid and nano-substance technologies has paved the way for advancements in these fields. His innovative patents and collaborations reflect his commitment to scientific progress and practical solutions.